Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Sean Brynjelsen

Sean Brynjelsen is recorded as CEO and Board Member at Eton Pharmaceuticals, Inc. (ETON). The proxy statement of Eton Pharmaceuticals, Inc. reports total compensation of $1,747,045 for Sean Brynjelsen in fiscal 2023, including a base salary of $591,862. Disclosed compensation is on record for 6 fiscal years. Sean Brynjelsen has spoken on 26 earnings calls and 1 other investor event across 1 company, most recently for Eton Pharmaceuticals, Inc. on August 13, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Eton Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Eton Pharmaceuticals, Inc. (ETON) $591,862 $1,747,045
2022 Eton Pharmaceuticals, Inc. (ETON) $569,541 $2,119,541
2021 Eton Pharmaceuticals, Inc. (ETON) $542,167 $2,092,292
2020 Eton Pharmaceuticals, Inc. (ETON) $475,833 $2,011,293
2019 Eton Pharmaceuticals, Inc. (ETON) $409,958 $1,946,408
2018 Eton Pharmaceuticals, Inc. (ETON) $332,313 $493,022

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 15 earlier activities